Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta2-agonists for acute bronchitis.

J Smucny1, C Flynn, L Becker

  • 1Family Medicine, State University of New York Upstate Medical University, 475 Irving Ave., Suite 200, Syracuse, New York, USA.

The Cochrane Database of Systematic Reviews
|February 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A fasting-mimicking diet in patients with mild-to-moderate Crohn's disease: a randomized controlled trial.

Nature medicine·2026
Same author

Maternal immune activation alters infant attentional processing in a nonhuman primate model.

Brain, behavior, & immunity - health·2025
Same author

Objective and subjective assessment of back shape and function in persons with and without low back pain.

Scientific reports·2025
Same author

Freiburg Neuropathology Case Conference : Posterior fossa tumour 15 years after microsurgical resection of a cerebellar pilocytic astrocytoma.

Clinical neuroradiology·2024
Same author

Different Glymphatic Kinetics in Spontaneous Intracranial Hypotension.

AJNR. American journal of neuroradiology·2024
Same author

Widespread service fragmentation for patients and families with tuberous sclerosis complex (TSC) in the Republic of Ireland.

Journal of rare diseases (Berlin, Germany)·2024
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
Same journal

Non-pharmacological interventions for anxiety and depression in Parkinson's disease.

The Cochrane database of systematic reviews·2026
Same journal

Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysis.

The Cochrane database of systematic reviews·2026
See all related articles

Beta2-agonists do not improve cough symptoms in children or adults with acute bronchitis without airflow obstruction. Potential benefits in patients with airflow limitation are not well-supported and must be weighed against side effects.

Area of Science:

  • Pulmonology
  • Pharmacology

Background:

  • Optimal treatment for acute bronchitis remains unclear.
  • Beta2-agonists are considered due to potential airflow limitation in patients with acute cough.

Purpose of the Study:

  • To evaluate the efficacy of beta2-agonists in improving acute bronchitis symptoms in patients without underlying pulmonary disease.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) published up to July 2003.
  • Searched Cochrane Library, MEDLINE, EMBASE, and Conference Proceedings.
  • Analyzed trials in children and adults separately, assessing cough scores and symptom resolution.

Main Results:

  • No significant benefits of beta2-agonists were found for cough in children or adults without airflow obstruction.

Related Experiment Videos

  • Some subgroups with airflow limitation showed reduced symptoms, but data were mixed and not robust.
  • Adverse effects like tremor were more common in patients receiving beta2-agonists.

    • Conclusions:

    • Evidence does not support routine beta2-agonist use for acute cough in children or adults without airflow obstruction.
    • Potential benefits in patients with airflow limitation require further investigation and risk-benefit assessment.